about
Negative health implications of sickle cell trait in high income countries: from the football field to the laboratorySickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease.MEK inhibitors, novel anti-adhesive molecules, reduce sickle red blood cell adhesion in vitro and in vivo, and vasoocclusion in vivoProthrombotic Risk Factors and Preventive Strategies in Adolescent Venous Thromboembolism.Tissue factor-dependent coagulation activation by heme: A thromboelastometry study.Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.Prospective study of sickle cell trait and venous thromboembolism incidenceRole of innate immunity-triggered pathways in the pathogenesis of Sickle Cell Disease: a meta-analysis of gene expression studiesPathophysiology and treatment of pulmonary hypertension in sickle cell diseaseCoagulation activation in sickle cell trait: an exploratory studyRisk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes.Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.Changes seen on computed tomography of the chest in mildly symptomatic adult patients with sickle cell disease.Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies.The contribution of red blood cells to thrombin generation in sickle cell disease: meizothrombin generation on sickled red blood cells.Emerging drugs for sickle cell anemia.Emerging point-of-care technologies for sickle cell disease screening and monitoring.Disseminated intravascular coagulation - new pathophysiological concepts and impact on management.Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.Red blood cells and thrombin generation in sickle cell diseasePrevalence and Clinical Characteristics of Rheumatoid Arthritis in an Inner City Population with Sickle Cell Disease.Rheumatoid Arthritis in Sickle-Cell Population: Pathophysiologic Insights, Clinical Evaluation and Management.
P2860
Q26862794-A333DD13-A219-4F9C-B324-9CEBBCF3624BQ27303155-F79CFAD6-8C04-4B66-808A-7AE282367B19Q27335195-F99AEB31-ACFE-40F9-9B39-D1B3386E91C9Q30251905-3F4CA95B-027A-4FEA-ACA0-4D63729A634BQ33596569-C1AD7E0D-803A-4FFC-B1E7-C3F299C36BFBQ34718108-9CA7817D-57CA-430E-9DDC-C4D2676FC157Q34964268-C04BF7B0-BDE9-4289-87DB-86D7DA96F0A7Q35863787-0B083C2E-1324-45EC-BBA7-F41195069609Q36596861-2ECBF0C9-D368-408A-93C8-969072803513Q36661960-E8D46C04-3C74-443C-BD53-94186B776D36Q36869433-08F0581C-7586-42D0-99A2-26F7CD8A52D4Q37033939-93C9D072-03FF-40C9-89BC-8C87ADEB5F7CQ37355678-61D07D27-5443-4126-8721-E640196D9613Q37370659-137078A5-EDC3-49BF-B731-C96B26F6C228Q37712306-57422A3B-3373-4536-A66E-7F4D9140E9B8Q38272226-E5D1E85D-E77C-4C48-9005-706EF4642B85Q38804432-FE4A2506-3F84-480D-BD9E-DA8207DE24C9Q38851774-424C3CA4-A512-477D-96CB-3070D69E5B89Q39588275-E822AB08-A3BE-4B57-BE02-AA496CEAA5F6Q39873700-B3FF0EF8-3129-4C45-A3B0-BD405A7CE735Q41703473-16FFC376-689E-40C8-BC10-23067970218DQ49520307-29824849-EA07-4A86-9CC4-D2DFB4471EF8
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hemostatic abnormalities in sickle cell disease.
@en
type
label
Hemostatic abnormalities in sickle cell disease.
@en
prefLabel
Hemostatic abnormalities in sickle cell disease.
@en
P1476
Hemostatic abnormalities in sickle cell disease
@en
P2093
Nigel S Key
P304
P356
10.1097/MOH.0B013E328363442F
P577
2013-09-01T00:00:00Z